Article Details

Freenome Secures $160 Million to Advance Cancer Detection Blood Test

Retrieved on: 2019-07-23 23:22:30

Tags for this article:

Click the tags to see associated articles and topics

Freenome Secures $160 Million to Advance Cancer Detection Blood Test. View article details on hiswai:

Excerpt

<div>Freenome's existing investors that also participated in the financing include Andreessen Horowitz, GV (formerly <b>Google Ventures</b>), Data Collective ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo